| ALG3 |
Homo sapiens |
|
ALG3 is differentially expressed in 108 experiments [124 up/104 dn]: 24 organism parts: peripheral blood [1 up/2 dn], testis [2 up/0 dn], ...; 31 disease states: normal [3 up/11 dn], glioblastoma [2 up/0 dn], ...; 27 cell types, 27 cell lines, 22 compound treatments and 18 other conditions. |
| ALG3, NOT, NOT56L |
|
NP_001135835.1 (Rattus norvegicus)
K09E4.2 (Caenorhabditis elegans)
ALG3 (Saccharomyces cerevisiae)
l(2)not (Drosophila melanogaster)
Alg3 (Mus musculus)
alg3 (Danio rerio)
(Compare orthologs)
|
|
|
| Glycosyltransferase, ALG3 |
|
|
| Congenital disorder of glycosylation, type Id |
|
|
| alpha-1,3-mannosyltransferase activity, dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity, endoplasmic reticulum membrane, protein amino acid glycosylation, integral to membrane |
|
|
|
Q92685
|
|
|
|
ENSG00000214160
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
None
|
Compound treatment |
|
|
Homo sapiens
|
Organism |
|
|
Peripheral blood
|
Organism part |
|
|
Glioblastoma
|
Disease state |
|
|
FLAP
|
Compound treatment |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
HNRPA2B
|
Compound treatment |
|
|
N/a
|
Test result |
|
|
Not applicable
|
Histology |
|
|
MDA-MB-231
|
Cell line |
|
|
MK886
|
Compound treatment |
|
|
Breast carcinoma
|
Disease state |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
Testis
|
Organism part |
|
|
MCF-7
|
Cell line |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
Control
|
Compound treatment |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
HeLa
|
Cell line |
|
|
SW480
|
Cell line |
|
|
SW620
|
Cell line |
|
|
Primary
|
Disease staging |
|
|
BT-474
|
Cell line |
|
|
Bone marrow
|
Organism part |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
Glucocorticoid sensitive
|
Phenotype |
|
|
Dimethyl sulfoxide
|
Compound treatment |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
Rapamycin
|
Compound treatment |
|
|
Grade IV
|
Tumor grading |
|
|
HL-60
|
Cell line |
|
|
Plasma cell
|
Cell type |
|
|
B lymphocyte
|
Cell type |
|
|
Malignant melanoma
|
Disease state |
|
|
T47D
|
Cell line |
|
|
MDA468
|
Cell line |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
Multiple myeloma
|
Disease state |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
HPL1
|
Cell line |
|
|
Methotrexate
|
Compound treatment |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Chondrocyte
|
Cell type |
|
|
Kidney cell
|
Cell type |
|
|
Spermatid
|
Cell type |
|
|
Differentiated
|
Cell type |
|
|
Naive
|
Cell type |
|
|
Monocyte
|
Cell type |
|
|
X-linked chronic granulomatous
|
Disease state |
|
|
T3bN1M0
|
Disease staging |
|
|
Cancer27
|
Replicate |
|
|
Epilepsy
|
Disease state |
|
|
U937
|
Cell line |
|
|
Spermatocyte
|
Cell type |
|
|
T47-D
|
Cell line |
|
|
Granulocyte
|
Cell type |
|
|
Epidermal keratinocyte
|
Cell type |
|
|
SkinEthic keratinocyte
|
Cell type |
|
|
Chronic lymphocytic leukemia
|
Disease state |
|
|
Skeletal muscle
|
Organism part |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
Cartilage
|
Organism part |
|
|
Seminiferous tubule
|
Organism part |
|
|
Osteoblast
|
Cell type |
|
|
Endometrioid carcinoma
|
Disease state |
|
|
Trichostatin A
|
Compound treatment |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
Liver
|
Organism part |
|
|
MCF7
|
Cell line |
|
|
GLI56
|
Cell line |
|
|
Enzo Labeling
|
Protocol type |
|
|
Cervical cancer
|
Disease state |
|
|
Psoriatic lesional biopsy
|
Clinical info |
|
|
Uninvolved biopsy
|
Clinical info |
|
|
Epidermal growth factor
|
Compound treatment |
|
|
GLI60
|
Cell line |
|
|
Caco-2
|
Cell line |
|
|
BT474
|
Cell line |
|
|
Heat-killed HL60 cell lysate
|
Infection |
|
|
Adipose-derived stem cell
|
Cell type |
|
|
Neutrophil
|
Cell type |
|
|
Kidney
|
Organism part |
|
|
Stage II
|
Disease staging |
|
|
Uterine cervix
|
Organism part |
|
|
Prostate
|
Organism part |
|
|
Cadmium chloride 2.5-hydrate
|
Compound treatment |
|
|
Lung adenocarcinoma
|
Disease state |
|
|
SKBR3
|
Cell line |
|
|
Control for heregulin
|
Compound treatment |
|
|
Fetal thyroid
|
Organism part |
|
|
White blood cells
|
Organism part |
|
|
Monocyte at intermediate diffe...
|
Cell type |
|
|
PC3
|
Cell line |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
Synovial fluid
|
Organism part |
|
|
Bis [(+)-tartrato] diantimonat...
|
Compound treatment |
|
|
Chronic myelogenous leukemia
|
Disease state |
|
|
Hypericin incubated, not irrad...
|
Growth condition |
|
|
Hypericin incubated, irradiate...
|
Growth condition |
|
|
Burkitt's lymphoma
|
Disease state |
|
|
Serum starvation + thymidine b...
|
Growth condition |
|
|
Fibroblast
|
Cell type |
|
|
Olfactory bulb
|
Organism part |
|
|
Superior cervical ganglion
|
Organism part |
|
|
Johnsen score count 10: full s...
|
Histology |
|
|
Epithelial cell
|
Cell type |
|
|
Astrocyte
|
Cell type |
|
|
Acute lymphocytic leukemia
|
Disease state |
|
|
Beta cell islets
|
Organism part |
|
|
Native skin
|
Cell type |
|
|
CodeLink Labeling
|
Protocol type |
|
|
Lymph node metastasis
|
Disease staging |
|
|
T4aNxMx
|
Disease staging |
|
|
Gastric cancer
|
Disease state |
|
|
Stage unknown
|
Disease staging |
|
|
Ethanol
|
Vehicle |
|
|
Kaposi's sarcoma
|
Disease state |
|
|
Monoclonal gammopathy of undet...
|
Disease state |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Pan paniscus
|
Organism |
|
|
Geriatric
|
Developmental stage |
|
|
Pediatric
|
Developmental stage |
|
|
Childhood acute myeloid leukem...
|
Disease state |
|
|
Well-functioning transplant
|
Clinical info |
|
|
DMSO
|
Vehicle |
|
|
None
|
Light |
|
|
Adenocarcinoma
|
Disease state |
|
|
Head and neck squamous cell ca...
|
Disease state |
|
|
PCep4 control vector transfect...
|
Gene modification |
|
|
ETat plasmid transfection
|
Gene modification |
|
|
Muscle invasive carcinoma
|
Disease state |
|
|
Adrenal cortex cell
|
Cell type |
|
|
Pergolide methanesulfonate
|
Compound treatment |
|
|
BL41K3
|
Cell line |
|
|
BJABK3
|
Cell line |
|
|
CD34+
|
Cell type |
|
|
Wild_type
|
Genotype |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
Stromal cell
|
Cell type |
|
|
Secretory cell
|
Cell type |
|
|
Stage I
|
Disease staging |
|
|
Control
|
Phenotype |
|
|
Wilms' tumor
|
Disease state |
|
|
U0126
|
Compound treatment |
|
|
Bladder mucosa
|
Organism part |
|
|
Bladder
|
Organism part |
|
|
4OH-tamoxifen
|
Compound treatment |
|
|
M-CSF
|
Compound treatment |
|
|
293
|
Cell line |
|
|
M1 macrophage
|
Cell type |
|
|
Pan troglodytes
|
Organism |
|
|
Granulocyte macrophage-colony ...
|
Compound treatment |
|
|
Heart
|
Organism part |
|
|
TIVE
|
Cell line |
|
|
Ulcerative colitis
|
Disease state |
|
|
ITV
|
Cell line |
|
|
Plasma cell leukemia
|
Disease state |
|
|
Duodenum
|
Organism part |
|
|
Cystic change
|
Histology |
|
|
HaCaT
|
Cell line |
|
|
Blood
|
Organism part |
|
|
Carcinoma in situ lesion
|
Disease state |
|
|
Senescence bypassed
|
Phenotype |
|
|
SM1
|
Cell line |
|
|
Experimental malaria-infected
|
Disease state |
|
|
T3aN0M0
|
Disease staging |
|
|
Refractory anemia with ringed ...
|
Clinical info |
|
|
Ovary
|
Organism part |
|
|
Benign nevi
|
Disease state |
|
|
Carboplatin resistant
|
Test result |
|
|
Carboplatin sensitive
|
Test result |
|
|
Stage III/3
|
Disease staging |
|
|
BJAB
|
Cell line |
|
|
Caudate nucleus
|
Organism part |
|
|
17beta-estradiol
|
Compound treatment |
|
|
Whole brain
|
Organism part |
|
|
Selenium
|
Compound treatment |
|
|
Macaca mulatta
|
Organism |
|
|
Affymetrix Labeling
|
Protocol type |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
|
|
|
Processing time: 0.128 secs.